ATE115409T1 - Glykoprotein-hormonrezeptor-moleküle. - Google Patents

Glykoprotein-hormonrezeptor-moleküle.

Info

Publication number
ATE115409T1
ATE115409T1 AT90908349T AT90908349T ATE115409T1 AT E115409 T1 ATE115409 T1 AT E115409T1 AT 90908349 T AT90908349 T AT 90908349T AT 90908349 T AT90908349 T AT 90908349T AT E115409 T1 ATE115409 T1 AT E115409T1
Authority
AT
Austria
Prior art keywords
hormone receptor
receptor molecule
glycoprotein hormone
stimulating hormone
hormone
Prior art date
Application number
AT90908349T
Other languages
English (en)
Inventor
Karoly Nikolics
Keith C Mcfarland
Deborah L Segaloff
Peter H Seeburg
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE115409T1 publication Critical patent/ATE115409T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90908349T 1989-05-05 1990-05-04 Glykoprotein-hormonrezeptor-moleküle. ATE115409T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34768389A 1989-05-05 1989-05-05

Publications (1)

Publication Number Publication Date
ATE115409T1 true ATE115409T1 (de) 1994-12-15

Family

ID=23364795

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94104166T ATE221123T1 (de) 1989-05-05 1990-05-04 Glykoprotein-hormonrezeptor-moleküle
AT90908349T ATE115409T1 (de) 1989-05-05 1990-05-04 Glykoprotein-hormonrezeptor-moleküle.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT94104166T ATE221123T1 (de) 1989-05-05 1990-05-04 Glykoprotein-hormonrezeptor-moleküle

Country Status (9)

Country Link
EP (3) EP0471030B1 (de)
JP (1) JPH04505103A (de)
AT (2) ATE221123T1 (de)
AU (1) AU5732190A (de)
DE (2) DE69033990T2 (de)
DK (2) DK0471030T3 (de)
ES (2) ES2068388T3 (de)
HK (1) HK1046429A1 (de)
WO (1) WO1990013643A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614363A (en) * 1990-01-25 1997-03-25 New England Medical Center Hospitals, Inc. TSH receptor
WO1991003483A1 (en) * 1989-09-08 1991-03-21 New England Medical Center Hospitals, Inc. Tsh receptor
EP0506890A4 (en) * 1989-12-20 1993-06-30 Nichols Institute Diagnostics Recombinant thyrotropin receptor
EP0475292B1 (de) * 1990-09-10 1999-06-30 Takeda Chemical Industries, Ltd. Menschlicher Rezeptor für luteinisierendes Hormon und Choriongonadotropin
JP3581148B2 (ja) * 1991-03-15 2004-10-27 アプライド・リサーチ・システムズ・アルス・ホールディング・エヌ・ブイ ヒト濾胞刺激ホルモンの受容体
WO1993020199A1 (en) * 1992-03-30 1993-10-14 Akzo Nobel N.V. Human gonadotropin receptor (fsh receptor)
US6033903A (en) * 1995-06-02 2000-03-07 Applied Research Systems, ARS Holding N.V. Method of expressing and secreting soluble extracellular domains of human gonadotropin hormone receptors
WO1997039131A1 (en) * 1996-04-15 1997-10-23 The Board Of Trustees Of The Leland Stanford Junior University Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
US5858716A (en) * 1997-05-30 1999-01-12 Smithkline Beecham Corporation H2CAA71 polynucleotides
EP1049779A2 (de) * 1998-01-20 2000-11-08 Wilex Biotechnology GmbH Lh-rezeptorgenpromoter für gewebenspezifischen genexpression
GB9909661D0 (en) 1998-06-06 1999-06-23 Rsr Ltd Assays for TSH receptor autoantibodies
CN103224562B (zh) 2001-08-23 2017-09-08 Rsr有限公司 促甲状腺素受体的表位区域和针对该区域的抗体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4560649A (en) * 1981-10-15 1985-12-24 Cornell Research Foundation Assaying for hLH or hCG with immobilized hormone receptors
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US4921808A (en) * 1986-06-25 1990-05-01 The Albany Medical College Of Union University Method for determining follicle stimulating hormone
WO1991003483A1 (en) * 1989-09-08 1991-03-21 New England Medical Center Hospitals, Inc. Tsh receptor
EP0433509B1 (de) * 1989-12-14 1996-11-13 B.R.A.H.M.S Diagnostica GmbH Polypeptide mit Thyrotropinrezeptor-Aktivität, kodierende Nukleinsäuresequenzen für solche Rezeptoren und Verwendung dieser Polypeptide
EP0506890A4 (en) * 1989-12-20 1993-06-30 Nichols Institute Diagnostics Recombinant thyrotropin receptor
FR2657014A1 (fr) * 1990-01-15 1991-07-19 Inst Nat Sante Rech Med Recepteur humain de la tsh. sequence codant pour ce recepteur.

Also Published As

Publication number Publication date
WO1990013643A2 (en) 1990-11-15
DK0471030T3 (da) 1995-05-29
JPH04505103A (ja) 1992-09-10
EP0471030A1 (de) 1992-02-19
DE69033990D1 (de) 2002-08-29
ATE221123T1 (de) 2002-08-15
EP1199361A3 (de) 2004-03-10
AU5732190A (en) 1990-11-29
DE69033990T2 (de) 2003-02-13
DE69015175D1 (de) 1995-01-26
ES2068388T3 (es) 1995-04-16
EP0614975A1 (de) 1994-09-14
HK1046429A1 (en) 2003-01-10
EP0614975B1 (de) 2002-07-24
DK0614975T3 (da) 2002-11-11
EP0471030B1 (de) 1994-12-14
EP1199361A2 (de) 2002-04-24
ES2180550T3 (es) 2003-02-16
WO1990013643A3 (en) 1991-01-10
DE69015175T2 (de) 1995-06-29

Similar Documents

Publication Publication Date Title
ATE115409T1 (de) Glykoprotein-hormonrezeptor-moleküle.
EP0671920A4 (de) Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv-verwandten krankheiten.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
TR24305A (tr) Blok kopolimer, bunu yapma metodu, bunun diamin oencueleri, bu tip diaminleri yapm
DE69133593D1 (de) Menschliches CNP-Gen und Vorläuferprotein
DK0669979T3 (da) C-C CKR-1, kemokinreceptor
DK143492A (da) Human-h2-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet
EP0786995A4 (de)
ATE95424T1 (de) Durch ''site-directed'' mutagenese modifzierte glukoprotein-hormone und verfahren zu deren verwendung.
ZA896558B (en) Method of treating skin injuries using thromboxane a2 receptor antagonists
ATE199167T1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
EE05497B1 (et) Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
DE69534723D1 (de) Einzelketten-Gonadotropin
DE69534597D1 (de) Melatoninrezeptoren mit hoher affinität und ihre verwendungen
FR2651435B1 (de)
DE69832197D1 (de) Rantes mutanten und deren therapeutische verwendungen
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
IT8620548A0 (it) Procedimento e dispositivo per la fabbricazione di prodotti in fibra di vetro, per esempio veli, feltri, filati e stoppini.
ATE139565T1 (de) Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
王殿洪 et al. PURIFICATION AND CHARACTERIZATION OF INSULIN RECEPTORS FROM HUMAN PLACENTA
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time